LAMBERTENGHI DELILIERS, GIORGIO
 Distribuzione geografica
Continente #
EU - Europa 38.326
NA - Nord America 23.895
AS - Asia 21.488
SA - Sud America 1.735
AF - Africa 432
OC - Oceania 72
Continente sconosciuto - Info sul continente non disponibili 15
Totale 85.963
Nazione #
US - Stati Uniti d'America 23.112
DE - Germania 11.551
GB - Regno Unito 10.521
CN - Cina 8.140
SG - Singapore 5.936
IT - Italia 4.016
SE - Svezia 3.089
RU - Federazione Russa 2.568
UA - Ucraina 1.700
HK - Hong Kong 1.566
FR - Francia 1.421
IN - India 1.310
VN - Vietnam 1.197
TR - Turchia 1.066
BR - Brasile 1.050
KR - Corea 966
NL - Olanda 947
IE - Irlanda 820
EU - Europa 783
FI - Finlandia 631
CA - Canada 561
CO - Colombia 428
BD - Bangladesh 284
JP - Giappone 243
CI - Costa d'Avorio 211
GR - Grecia 209
PL - Polonia 194
ID - Indonesia 184
DK - Danimarca 138
BE - Belgio 109
ES - Italia 108
MX - Messico 102
AR - Argentina 95
UZ - Uzbekistan 77
IQ - Iraq 70
PK - Pakistan 57
AU - Australia 55
CZ - Repubblica Ceca 52
ZA - Sudafrica 50
AT - Austria 45
SA - Arabia Saudita 43
CH - Svizzera 41
EC - Ecuador 40
VE - Venezuela 39
TH - Thailandia 37
PH - Filippine 36
RO - Romania 31
KE - Kenya 28
JO - Giordania 27
AE - Emirati Arabi Uniti 26
MA - Marocco 26
CR - Costa Rica 24
LB - Libano 24
IL - Israele 21
EG - Egitto 20
PY - Paraguay 20
MY - Malesia 19
NP - Nepal 19
UY - Uruguay 19
CL - Cile 18
IR - Iran 18
PT - Portogallo 18
TW - Taiwan 16
LT - Lituania 15
JM - Giamaica 14
PE - Perù 14
NZ - Nuova Zelanda 13
OM - Oman 13
AZ - Azerbaigian 12
TN - Tunisia 12
BG - Bulgaria 11
SN - Senegal 11
TT - Trinidad e Tobago 11
AL - Albania 10
ET - Etiopia 10
HU - Ungheria 10
LU - Lussemburgo 10
BO - Bolivia 9
PA - Panama 9
PS - Palestinian Territory 9
BH - Bahrain 8
DZ - Algeria 8
HN - Honduras 8
KG - Kirghizistan 8
KZ - Kazakistan 8
SV - El Salvador 8
GT - Guatemala 7
MD - Moldavia 7
NI - Nicaragua 7
NO - Norvegia 7
AM - Armenia 6
CY - Cipro 6
DO - Repubblica Dominicana 6
NG - Nigeria 6
QA - Qatar 6
RS - Serbia 6
BA - Bosnia-Erzegovina 5
SI - Slovenia 5
SO - Somalia 5
BS - Bahamas 4
Totale 86.596
Città #
Southend 9.359
Frankfurt am Main 7.338
Singapore 3.253
Beijing 2.280
Ashburn 2.161
Chandler 1.922
Jacksonville 1.520
Hong Kong 1.458
Seattle 1.376
San Jose 1.283
Milan 1.141
Princeton 1.001
Wilmington 894
Dublin 811
Redmond 661
Dallas 660
Bengaluru 646
Council Bluffs 631
Boise 593
Nanjing 553
Mountain View 550
Ann Arbor 545
Los Angeles 501
Serra 493
Dearborn 486
Somerville 484
Sakarya 438
Andover 430
Hefei 418
Lauterbourg 407
Bogotá 404
Toronto 392
Ho Chi Minh City 375
Santa Clara 365
Woodbridge 356
New York 334
Boardman 316
Houston 313
Shanghai 308
Des Moines 307
Fairfield 304
Hanoi 287
Moscow 264
Buffalo 251
Berlin 248
Guangzhou 233
Abidjan 207
Hangzhou 207
Nanchang 205
Jinan 203
Athens 189
Shenyang 184
Saint Petersburg 161
Helsinki 160
Tianjin 155
Tokyo 152
Warsaw 148
Cangzhou 143
Rome 140
Kiez 136
Eitensheim 126
Changsha 125
Grafing 122
Columbus 116
Bitonto 115
Hebei 115
Hanover 113
Phoenix 109
São Paulo 100
Brussels 98
Munich 95
The Dalles 93
Zhengzhou 92
Pisa 89
Auburn Hills 88
Nürnberg 87
Fuzhou 81
Hamburg 80
Jiaxing 80
Kunming 80
Roxbury 80
Naples 79
Verona 72
Turin 66
Shenzhen 65
Cambridge 63
Redwood City 63
Jakarta 62
Seoul 61
San Diego 59
London 57
Dong Ket 53
Istanbul 52
Quanzhou 49
Ningbo 46
Orem 46
Payette 46
Da Nang 45
Mumbai 43
Norwalk 43
Totale 54.894
Nome #
Low dose dasatinib in refractory imatinib mesylate chronic myeloid leukemia : case report 997
Personalized treatment strategies for elderly patients with myelodysplastic syndromes 712
Burnout e oncologia: una ricerca multicentrica 571
Clinical-biological characterization of variant B chronic lymphocytic leukemia, characterized by a mantle cell lymphoma-like immunophenotype, t(11;14)(q13;q32) negative 507
Single institution retrospective analysis of bronchoalveolar lavage as etiological diagnostic tool for pulmonary infiltrates in patients with haematological malignancies 464
RAS mutations vontribute to evolution of chronic myelomonocytic leukemia to the proliferative variant 457
Anti-L-NGFR and -CD34 Monoclonal Antibodies Identify Multipotent Mesenchymal Stem Cells in Human Adipose Tissue 450
Upfront treatment of mantle cell lymphoma by sequential high dose immunochemotherapy supported by in vivo-purged stem cell double autologous transplantation : a single institution experience 391
Identification of specific transcriptional patterns associated with hyperdiploidy in multiple myeloma 380
Low-dose subcutaneous alemtuzumab in refractory chronic lymphocytic leukaemia (CLL) : results of a prospective, single-arm multicentre study 379
ABVD versus modified Stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin lymphoma : final results of a multicenter, randomized trial by the Intergruppo Italiano Linfomi 366
Alterazioni quantitative e qualitative dei leucociti 346
Frontline antiviral therapy in a series of HCV-related low grade non-Hodgkin lymphoma 340
A distinctive trascriptional profile characterizes the chromosome 17p loss in B-cell chronic lymphocytic leukemia 337
Long-term clinical and molecular outcomes following RIC-allogeneic HSCT from HLA-identical sibling in patients with advanced mycosis fungoides and Sézary syndrome 331
Activity of sphingosine kinase inhibitor in Chronic Myelogenous Leukemia cells sensitive and resistant to Imatinib Mesylate 327
A pilot study of low-dose subcutaneous alemtuzumab therapy for patients with hemotherapy-refractory chronic lymphocytic leukemia 322
TCRbeta Gene Rearrangements for Detection and Monitoring of Minimal Residual Disease after Allogenic Stem-Cell Transplantation in Patients with Advanced Mycosis Fungoides and Sézary Syndrome 321
An integrative genomic approach reveals coordinated expression of intronic miR-335, miR-342, and miR-561 with deregulated host genes in multiple myeloma 316
High dose sequential chemotherapy with autologous transplantation versus dose-dense chemotherapy MegaCEOP as first line treatment in poor-prognosis diffuse large cell lymphoma : an "Intergruppo Italiano Linfomi" randomized trial 312
Prognostic implications of the European consensus for grading of bone marrow fibrosis in chronic idiopathic myelofibrosis 308
Prevalence of ras gene mutations in the context of a molecular classification of multiple myeloma 308
Autologous haematopoietic stem cell transplantation without CD34+ cell selection in refractory Crohn's disease 305
Four year survival after trans-jugular intrahepatic porto-systemic shunt for veno-occlusive disease following autologous bone marrow transplantation 298
Combined lamivudine and adefovir dipivoxil treatment allows safe and long-term compath-1H therapy in refractory B-cell chronic lymphocytic leukemia with HBV reactivation 298
Autologous haematopoietic stem cell transplantation for refractory Crohn's disease : up to 2 year follow up without CD34+ cell selection 293
Induction of neurotrophin expression via human adult mesenchymal stem cells : implication for cell therapy in neurodegenerative diseases 293
Ineffective hematopoiesis and markers of angiogeneisis in myelodysplastic syndromes 293
Adefovir added to lamivudine for hepatitis B recurrent infection in refractory B-cell chronic lymphocytic leukemia on prolonged therapy with Campath-1H 291
Analysis of CD44 expression in monoclonal gammopathies : correlation between gene expression level and flow cytometry findings 289
Prognostic implications of the european consensus for grading of bone marrow fibrosis in chronic idiopathic myelofibrosis 288
Apoptosis taqman low-density array : analysis of programmed cell death patway in CLL 281
Deregulation of MIR-221/222 cluster affects P27 expression in multiple myeloma 279
Bone microenvironment cells reveal a different gene expression profiling in multiple myeloma patients as compared to healthy subjects : potential relationship with the bone status 278
Integrative genomic analysis of trisomy 12 abnormality in B-cell chronic lymphocytic leukemia 276
Biological and clinical relevance of quantitative global methylation of repetitive DNA sequences in chronic lymphocytic leukemia 276
Autologous haematopoietic stem cell transplantation for refractory Crohn's disease : up to 2 year follow up with unselected stem cells 273
A novel fish-based normalization procedure for whole genome microarrays detecting accurate local copy numbers : application to multiple myeloma 273
Identification of specific transcriptional patterns associated with hyperdiploidy in multiple myeloma 271
Gene expression signature of the apoptotic patway in indolent CLL by low-density array technology 270
A SNP microarray and FISH-based procedure to detect allelic imbalances in multiple myeloma : an integrated genomics approach reveals a wide gene dosage effect 270
FISH characterization of t(8;12)(q12;p13) observed as the sole karyotypic anomaly in a myelodysplastic syndrome patient 270
Oxidative stress is increased in primary and post-polycythemia vera myelofibrosis 269
Molecular Classification of Multiple Myeloma : A Distinct Transcriptional Profile Characterizes Patients Expressing CCND1 and Negative for 14q32 Translocations 267
Gene Expression Profiling of Plasma Cell Dyscrasias Reveals Molecular Heterogeneity of Multiple Myeloma 266
Bone marrow endothelial progenitors are defective in systemic sclerosis 265
Evolving pattern of microbial susceptibility to antibiotics in a HSCT unit 264
Circulating versus progenitor endothelial cells are abnormal in patients with different types of von willebrand disease and correlate with markers of angiogenesis : a cohort study of 74 cases” 262
Establishment of an interlukin-6 independent variant (CMA-03/06) of the human myeloma cell line CMA-03 : biological molecular characterization by a genomic integrative analisys 262
Clinico-biological characterization of a subset of variant B-CLL, defined according to a combined cytofluorimetric/fish diagnostic approach 260
MicroRNA genes associated with genomic alterations or gene expression modulation contribute to enhance genetic heterogeneity in Multiple Myeloma 259
Metalloproteinase alterations in the bone marrow of ALS patients 259
Bone marrow monocytes in histiocytosis X acquire some phenotypic features of Langerhans cells in long term bone marrow cultures 259
Evaluation of deoxycholate amphotericin-B toxicity after HSCT 258
Molecular and transcriptional characterization of 17P loss in B-cell chronic lymphocytic leukemia 258
ZAP-70 immunoreactivity is a prognostic marker of disease progression in chronic lymphocytic leukemia 256
Bone marrow endothelial progenitors in Systemic Sclerosis : evidence for apoptotic phenotype and correlation with anti-endothelial cell antibodies 256
Establishment of an interlukin-6 independent variant (CMA-03/06) of the human myeloma cell line CMA-03 : biological and molecular characterization by a genomic integrative analisys 255
Analisys of bone marrow hematopoietic and mesenchymal precursors in patients with amyotrophic lateral sclerosis 254
Molecular definition of 17P11-P12 amplification in multiple myeloma 252
Evidence of graft-versus-leukaemia following allogeneic haematopoietic stem cell transplantation in patients with advanced mycosis fungoides and Sézary syndrome 252
Utilizzo di un dispositivo nano tecnologico per fish miniaturizzata (microFind) per l’identificazione di lesioni genetiche in campioni con scarsità cellulare : applicazione nel mieloma multiplo 252
Dioxin exposure of human CD34(+) hemopoietic cells induces gene expression modulation that recapitulates its in vivo clinical and biological effects 252
Evalutation of TIE2-expressing monocytes in myeloid disorders 251
Bone microenvironment cells reveals a different gene expression profyling in multiple myeloma patients in relation to the bone status 251
Diagnostic Role of Flow Cytometry Analysis of Bioptical Samples in the Diagnosis of Lymphoid Tumors 250
Defective vasculogenesis in Systemic Sclerosis is related to apoptotic phenotype in bone marrow endothelial progenitors 249
Prevalence of ras gene mutations in the context of a molecular classification of multiple myeloma 249
Markers of angiogenesis in von willbrand disease 249
Chronic myelomonocytic leukemia : identification of molecular abnormalities and monitoring of ras mutations-driven disease progression by allele-specific PCR 249
Endothelial precursors and mature endothelial cells are increased in the peripheral blood of myelodysplastic syndromes 248
First-line treatment with bendamustine and rituximab, in patients with intermediate-/high-risk splenic marginal zone lymphomas 248
Miniaturized fish approach (microfindtm) for detection of genetic lesions from scarce cell samples : application to multiple myeloma 246
Patterns of global DNA methylation identify early stage (Binet A) CLL patients with higher risk of disease progression 246
Functional alteration of bone marrow mesenchymal stem cells of Amyotrophic Lateral Sclerosis Patients 245
Frontline treatment with the combination fludarabine-cyclophosphamide in low-grade non-follicular non-Hodgkin lymphoma : a long term updating of GISL LL02 trial 245
Conjunctival hemorrhagic events associated with imatinib 244
Biological and molecular characterization by integrative genomics approach of CMA-03/06, a newly established interleukin-6 independent variant of the CMA-03 human myeloma cell line 243
IGHV gene analysis in chronic lymphocytic leukemia 243
Low dose campath 1-H is highly effective and safe in advanced chronic CLL 242
Microfind approach for fish detection of genetic lesions from scarce cell samples in multiple myeloma samples 242
Bone marrow glycophorin-positive erythroid cells of myelodysplastic patients responding to high-dose rHuEPO therapy have a different gene expression pattern from those of nonresponders 241
Deregulation of MIR-221/222 cluster affects P27 expression in multiple myeloma 241
Circulating Versus Progenitor Endothelial Cells Levels Are Abnormal in Patients with Different Types of Von Willebrand Disease and Correlate with Markers of Angiogenesis 240
Establishment of an interlukin-6 independent variant (CMA-03/06) of the human myeloma cell line CMA-03 : biological and molecular characterization by a genomic integrative analisys 239
Central nervous system disease in multiple myeloma patients receiving bortezomid to treat post transplant relapse 238
Survivin expression in "low-risk" and "high-risk" myelodysplastic syndromes 238
Low-dose subcutaneous alemtuzumab therapy for patients with refractory chronic lymphoblastic leukaemia (B-CLL) 238
G-CSF after autologous hemopoietic stem cell transplantation in malignant lymphoma 238
Chronic idiopathic myelofibrosis complicated by pulmonary arterial hypertension is distinctively characterized by endothelial progenitor cell insufficiency and increased angiogenesis 237
C-Kit expression is involved in fibroblast dysfunction in systemic sclerosis 237
Multilineage potential of human amniotic fluid cells 237
A novel fish-based normalization procedure for whole genome microarrays detection accurate local copy numbers : application to multiple myeloma 236
ESTABLISHMENT OF AN INTERLEUKIN-6 INDEPENDENT VARIANT (CMA-03/06) OF THE HUMAN MYELOMA CELL LINE CMA-03 : BIOLOGICAL AND MOLECULAR CHARACTERIZATION BY A GENOMIC INTEGRATIVE ANALYSIS 235
Integrative genomics based on microarrays analyses reveals a correlation between allelic imbalances and gene expression patterns in multiple myeloma 234
Evolution of empirical antifungal therapy in a bone marrow transplantation unit 233
11Q13 polisomy and absence of IGH translocations and chromosome 13Q14 deletion characterize a distinct subgroup of multiple myeloma patients expressing CCND 233
Isolation and characterization of L-NGFR(+) mesenchymal stem cells from adipose tissue and bone marrow: a comparison between the two sources 232
Analysis of Stereotyped IGHV distribution in a series of 1133 chronic lymphocytic leukemia patients : the experience of a multicenter Italian Study Group 232
Pathogenetic role of mature and progenitor endothelial cells in pre-eclampsia 231
Totale 29.274
Categoria #
all - tutte 205.243
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 205.243


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.849 0 0 0 0 0 0 0 0 0 0 2.356 493
2021/20224.588 506 109 217 139 241 267 572 224 680 410 250 973
2022/20236.479 878 645 597 650 888 1.318 125 380 591 66 230 111
2023/20248.469 116 310 175 309 1.026 586 1.026 1.076 451 984 1.147 1.263
2024/202511.131 1.132 1.336 843 1.344 645 281 160 940 423 828 724 2.475
2025/202616.907 1.892 1.314 1.782 1.495 1.697 1.368 1.893 954 1.915 1.541 1.056 0
Totale 90.146